PL2694971T3 - Testy receptora steroidowego do wykrywania komórek nowotworowych - Google Patents

Testy receptora steroidowego do wykrywania komórek nowotworowych

Info

Publication number
PL2694971T3
PL2694971T3 PL12716825T PL12716825T PL2694971T3 PL 2694971 T3 PL2694971 T3 PL 2694971T3 PL 12716825 T PL12716825 T PL 12716825T PL 12716825 T PL12716825 T PL 12716825T PL 2694971 T3 PL2694971 T3 PL 2694971T3
Authority
PL
Poland
Prior art keywords
detection
cancer cells
steroid receptor
receptor tests
tests
Prior art date
Application number
PL12716825T
Other languages
English (en)
Inventor
David A. Chianese
Original Assignee
Menarini Silicon Biosystems S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Silicon Biosystems S.P.A. filed Critical Menarini Silicon Biosystems S.P.A.
Publication of PL2694971T3 publication Critical patent/PL2694971T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/5759—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds localised on the membrane of tumour or cancer cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/723—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/54—Determining the risk of relapse

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
PL12716825T 2011-04-01 2012-03-30 Testy receptora steroidowego do wykrywania komórek nowotworowych PL2694971T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161470618P 2011-04-01 2011-04-01
US13/432,248 US20120252038A1 (en) 2011-04-01 2012-03-28 Steroid receptor assays
PCT/US2012/031338 WO2012135560A1 (en) 2011-04-01 2012-03-30 Steroid receptor assays for detecting tumor cells
EP12716825.0A EP2694971B1 (en) 2011-04-01 2012-03-30 Steroid receptor assays for detecting tumor cells

Publications (1)

Publication Number Publication Date
PL2694971T3 true PL2694971T3 (pl) 2020-11-02

Family

ID=46927724

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12716825T PL2694971T3 (pl) 2011-04-01 2012-03-30 Testy receptora steroidowego do wykrywania komórek nowotworowych

Country Status (21)

Country Link
US (1) US20120252038A1 (pl)
EP (1) EP2694971B1 (pl)
JP (2) JP2014513283A (pl)
KR (1) KR20140019823A (pl)
CN (1) CN103608681A (pl)
BR (1) BR112013025287A2 (pl)
CA (1) CA2831567A1 (pl)
CY (1) CY1123191T1 (pl)
DK (1) DK2694971T3 (pl)
ES (1) ES2793485T3 (pl)
HR (1) HRP20200860T1 (pl)
HU (1) HUE050711T2 (pl)
IL (1) IL228564B (pl)
LT (1) LT2694971T (pl)
MX (1) MX360225B (pl)
PL (1) PL2694971T3 (pl)
PT (1) PT2694971T (pl)
RS (1) RS60678B1 (pl)
SI (1) SI2694971T1 (pl)
SM (1) SMT202000270T1 (pl)
WO (1) WO2012135560A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6348115B2 (ja) * 2012-10-26 2018-06-27 ザ ユニバーシティー オブ クイーンズランド がん療法のためのエンドサイトーシス阻害剤および抗体の使用
CN109975097A (zh) * 2019-04-18 2019-07-05 山东师范大学 一种基于适配体的肿瘤细胞染色探针组合
US12405216B2 (en) * 2019-04-28 2025-09-02 Essenlix Corporation Rapid pathology/cytology without wash

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292638A (en) * 1990-12-07 1994-03-08 The Regents Of The University Of California Method of determining functional estrogen receptors for prognosis of cancer
CA2077781A1 (en) * 1991-09-23 1993-03-24 James W. Bacus Method and apparatus for automated assay of biological specimens
JP3996644B2 (ja) 1996-06-07 2007-10-24 イムニベスト・コーポレイション 外部及び内部勾配を有する磁気分離
DE69941689D1 (de) * 1998-02-12 2010-01-07 Univ Texas Verfahren und reagenzien zur raschen und effizienten isolierung zirkulierender krebszellen
EP1360496A4 (en) * 2001-02-16 2005-03-09 Immunivest Corp METHOD AND REAGENTS FOR THE QUICK AND EFFICIENT INSULATION OF CIRCULATING CANCER CELLS
WO2003019141A2 (en) * 2001-08-23 2003-03-06 Immunivest Corporation Analysis of circulating tumor cells, fragments, and debris
KR20040047971A (ko) * 2001-10-26 2004-06-05 이뮤니베스트 코포레이션 동일 샘플상에서의 광범위 핵산 및 이의 형태학적 특질에대한 다중 매개변수 분석법
CN1871517A (zh) * 2002-02-19 2006-11-29 免疫公司 快速有效分离循环癌细胞的方法和试剂
US7011794B2 (en) 2002-11-25 2006-03-14 Immunivest Corporation Upon a cartridge for containing a specimen sample for optical analysis
US20040171091A1 (en) * 2003-02-27 2004-09-02 Cell Work, Inc. Standardized evaluation of therapeutic efficacy based on cellular biomarkers
WO2004076643A2 (en) * 2003-02-27 2004-09-10 Immunivest Corporation CIRCULATING TUMOR CELLS (CTC’s): EARLY ASSESSMENT OF TIME TO PROGRESSION SURVIVAL AND RESPONSE TO THERAPY IN METASTATIC CANCER PATIENTS
JP5078100B2 (ja) * 2006-04-18 2012-11-21 ウェルスタット バイオロジクス コーポレイション 循環癌細胞におけるステロイド受容体の検出および処置
CA2688049A1 (en) * 2007-05-31 2008-12-04 Dako Denmark A/S Methods for utilizing esr copy number changes in breast cancer treatments and prognoses
US20090061456A1 (en) * 2007-08-30 2009-03-05 Allard William J Method for predicting progression free and overall survival at each follow-up time point during therapy of metastatic breast cancer patients using circulating tumor cells
EP2229441B1 (en) * 2007-12-12 2014-10-01 The Board of Trustees of The Leland Stanford Junior University Method and apparatus for magnetic separation of cells
JP2010151678A (ja) * 2008-12-25 2010-07-08 Olympus Corp 大腸癌の診断方法および大腸癌診断用キット
WO2011002649A1 (en) * 2009-06-30 2011-01-06 Veridex, Llc Analysis of circulating tumor-related microparticles
BR112013000433A2 (pt) * 2010-07-07 2016-05-17 Univ Michigan diagnóstico e tratamento de câncer de mama

Also Published As

Publication number Publication date
JP2014513283A (ja) 2014-05-29
US20120252038A1 (en) 2012-10-04
LT2694971T (lt) 2020-08-10
IL228564B (en) 2018-08-30
DK2694971T3 (da) 2020-06-02
EP2694971A1 (en) 2014-02-12
SMT202000270T1 (it) 2020-09-10
EP2694971B1 (en) 2020-03-04
IL228564A0 (en) 2013-12-31
ES2793485T3 (es) 2020-11-16
MX2013011428A (es) 2014-06-23
JP2018021934A (ja) 2018-02-08
JP6707505B2 (ja) 2020-06-10
WO2012135560A1 (en) 2012-10-04
HUE050711T2 (hu) 2020-12-28
RS60678B1 (sr) 2020-09-30
SI2694971T1 (sl) 2020-09-30
KR20140019823A (ko) 2014-02-17
CA2831567A1 (en) 2012-10-04
PT2694971T (pt) 2020-06-16
HRP20200860T1 (hr) 2020-09-04
CY1123191T1 (el) 2021-10-29
BR112013025287A2 (pt) 2017-11-14
CN103608681A (zh) 2014-02-26
MX360225B (es) 2018-10-25

Similar Documents

Publication Publication Date Title
PL2890717T3 (pl) Testy i zestawy diagnostyczne do wykrywania receptora folianu
DK2716766T3 (da) Indretning til detektering af kopiantal af føtale kromosomer eller tumorcellekromosomer
EP2707719A4 (en) DEVICE FOR DETECTING TUMOR CELLS
EP2585833A4 (en) Methods for detecting cancer
HUE040455T2 (hu) T-sejt aktiválás inhibitorai
DK2732260T3 (da) Prøveopsamlingskit
PT2788767T (pt) Método de detecção de adutos de nucleosoma
HUE056915T2 (hu) Plazma-DNS mutációs analízise a rák detektálása céljából
SG11201501200XA (en) Methods for predicting risk of developing hypertension
EP2859554A4 (en) MEMORY CELL DETECTION
EP2742123A4 (en) ISOLATION AND DETECTION OF CANCER CELLS
ZA201501317B (en) Epcam aptamer for detection of cancer stem cells
EP2726628A4 (en) METHOD FOR DETECTING GENEUS GENES
EP2841951A4 (en) PROCESS FOR DETECTING ALLOSTERIC PROTEIN MODULATORS
PT2876447T (pt) Método para deteção de cancro
EP2748615A4 (en) DEVELOPMENT AND USE OF FLUORESCENT PROBLEMS FROM UNBUNDLED BILIRUBIN
BR112015003931A2 (pt) composição de teste para detecção de cãncer
EP2851688A4 (en) MARKER FOR THE DETECTION OF PANCREATIC CANCER
IL228636A0 (en) Biomarkers for predicting sensitivity to cancer treatments
EP2711515A4 (en) PARTICLE MATERIAL SENSOR
EP2762873A4 (en) METHOD FOR SPECIFIC DETECTION OF A TEST SUBSTANCE
FI10014U1 (fi) Laite näytekappaleiden automatisoitua paljastamista varten
EP2795304A4 (en) ELECTROCHEMICAL SENSORS
DE102011013002B8 (de) Durchströmbare Messzelle
SI2639312T1 (sl) Imunski test za detekcijo miRNA